J. Govan

发表

Mouse beta defensin-1 is a functional homolog of human beta defensin-1

D. Davidson, J. Dorin, F. Kilanowski, 1998, Mammalian Genome.

Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex

P. Vandamme, T. Coenye, E. Mahenthiralingam, 2000, Journal of Clinical Microbiology.

Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

R. Goldstein, J. Govan, A. Holmes, 1998, Emerging infectious diseases.

Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.

D. Davidson, M. K. Sidhu, A. Hill, 2014, The Lancet. Respiratory medicine.

Explorer Atorvastatin as a stable treatment in bronchiectasis : a randomised controlled trial

D. Davidson, M. K. Sidhu, A. Hill, 2017 .

Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium

G. Mclachlan, P. Tennant, L. Glendinning, 2015, PloS one.

Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations.

W. Martone, J. Lipuma, R. Anderson, 1989, Reviews of infectious diseases.

Edinburgh Research Explorer Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens

P. Barran, J. Dorin, D. Campopiano, 2018 .

Peptide Fragments of a (cid:1) -Defensin Derivative with Potent Bactericidal Activity (cid:1)

Martin De Cecco, D. Uhrín, P. Barran, 2010 .

Covalent Dimer Species of (cid:2) -Defensin Defr1 Display Potent Antimicrobial Activity against Multidrug-Resistant Bacterial Pathogens (cid:1)

P. Barran, J. Dorin, D. Campopiano, 2007 .

Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins

J. Costerton, R. Irvin, J. Fyfe, 1981, Antimicrobial Agents and Chemotherapy.

Burkholderia cepacia Produces a Hemolysin That Is Capable of Inducing Apoptosis and Degranulation of Mammalian Phagocytes

J. Govan, I. Poxton, Michael L. Hutchison, 1998, Infection and Immunity.

Assessment of Fluorescent In Situ Hybridization and PCR-Based Methods for Rapid Identification of Burkholderia cepacia Complex Organisms Directly from Sputum Samples

J. Govan, A. Brown, 2007, Journal of Clinical Microbiology.

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

D. Porteous, D. Davidson, J. Dorin, 1995, Nature Genetics.

The Burkholderia cepacia Complex and Cytokine Induction: An Inflammatory Tale: Commentary on the article by Reddi et al. on page 297

J. Govan, 2003, Pediatric Research.

Growth in Stewart's medium is a simple, rapid and inexpensive screening tool for the identification of Burkholderia cepacia complex.

P. Vandamme, E. Vanlaere, J. Govan, 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Lung Pathology in Response to Repeated Exposure to Staphylococcus aureus in Congenic Residual Function Cystic Fibrosis Mice Does Not Increase in Response to Decreased CFTR Levels or Increased Bacterial Load

D. Davidson, J. Dorin, P. Teague, 2004, Pathobiology.

The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.

T. S. Wilkinson, R. Hancock, C. Haslett, 2010, American journal of respiratory cell and molecular biology.

Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease.

J. Govan, J. Govan, C. Wathen, 1998, Respiratory medicine.

In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia

J. Govan, C. Doherty, J. Govan, 1993, Antimicrobial Agents and Chemotherapy.